Dr. Lal PathLabs Limited is one of Bharat’s leading consumer healthcare brand in diagnostic services. The share price is currently 42% down from its lifetime high. It is constantly earning profit and has reduced its debt in the past few years. the company is also maintaining a healthy dividend yield. Promoter has not pledged their shares. So it is a good buy currently as the whole market is at a premium valuation and such gems are hard to find which are 42% down from lifetime high. Good for Investment purpose.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.